<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sen R</submitter><funding>BLRD VA</funding><funding>NIAMS NIH HHS</funding><pagination>232-241</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9892177</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>75(2)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>This study was conducted to assess the utility of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in predicting radiographic sacroiliitis and active disease in axial spondyloarthritis (SpA) and to explore the association between use of a tumor necrosis factor inhibitor (TNFi) and these laboratory values compared with traditional inflammatory markers.&lt;h4>Methods&lt;/h4>Observational data from the Program to Understand the Longterm Outcomes in Spondyloarthritis (PULSAR) registry were analyzed. We generated receiver operating characteristic curves to calculate laboratory cutoff values; we used these values in multivariable logistic regression models to identify associations with radiographically confirmed sacroiliitis and active disease. We also use</pubmed_abstract><journal>Arthritis &amp; rheumatology (Hoboken, N.J.)</journal><pubmed_title>Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Biomarkers in Axial Spondyloarthritis: Observational Studies From the Program to Understand the Longterm Outcomes in Spondyloarthritis Registry.</pubmed_title><pmcid>PMC9892177</pmcid><funding_grant_id>IK2 BX004523</funding_grant_id><funding_grant_id>T32 AR007534</funding_grant_id><pubmed_authors>Cheng E</pubmed_authors><pubmed_authors>Kim E</pubmed_authors><pubmed_authors>Hashim M</pubmed_authors><pubmed_authors>Napier RJ</pubmed_authors><pubmed_authors>Fernandez A</pubmed_authors><pubmed_authors>Reimold A</pubmed_authors><pubmed_authors>Sen R</pubmed_authors><pubmed_authors>Maier KD</pubmed_authors><pubmed_authors>Raychadhuri SP</pubmed_authors><pubmed_authors>Walsh JA</pubmed_authors><pubmed_authors>Kerr GS</pubmed_authors><pubmed_authors>Fang MA</pubmed_authors><pubmed_authors>Chang E</pubmed_authors><pubmed_authors>Caplan L</pubmed_authors><pubmed_authors>Anderson ER</pubmed_authors><pubmed_authors>Hou JK</pubmed_authors><pubmed_authors>Manning ES</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Biomarkers in Axial Spondyloarthritis: Observational Studies From the Program to Understand the Longterm Outcomes in Spondyloarthritis Registry.</name><description>&lt;h4>Objectives&lt;/h4>This study was conducted to assess the utility of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in predicting radiographic sacroiliitis and active disease in axial spondyloarthritis (SpA) and to explore the association between use of a tumor necrosis factor inhibitor (TNFi) and these laboratory values compared with traditional inflammatory markers.&lt;h4>Methods&lt;/h4>Observational data from the Program to Understand the Longterm Outcomes in Spondyloarthritis (PULSAR) registry were analyzed. We generated receiver operating characteristic curves to calculate laboratory cutoff values; we used these values in multivariable logistic regression models to identify associations with radiographically confirmed sacroiliitis and active disease. We also use</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-03-18T14:10:42.241Z</modification><creation>2025-05-29T21:30:56.765Z</creation></dates><accession>S-EPMC9892177</accession><cross_references><pubmed>36053919</pubmed><doi>10.1002/art.42333</doi></cross_references></HashMap>